Porton Pharma Solutions Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Cash & Equivalents	739.68	1,475	1,967	2,850	1,217	1,262
Trading Asset Securities	588.05	-	-	-	-	4.14
Cash & Short-Term Investments	1,328	1,475	1,967	2,850	1,217	1,266
Cash Growth	-5.33%	-25.02%	-31.01%	134.24%	-3.90%	7.77%
Accounts Receivable	964.26	829.5	690.57	1,506	1,088	405.33
Other Receivables	29.48	36.4	44.99	60.91	66.74	22.95
Receivables	993.74	865.9	735.56	1,567	1,154	428.28
Inventory	696.91	771.31	717.07	902.2	757.39	429.54
Other Current Assets	132.34	129.63	235.13	142.9	82.2	58.02
Total Current Assets	3,151	3,241	3,654	5,463	3,211	2,182
Property, Plant & Equipment	3,979	4,100	4,212	3,381	2,316	1,552
Long-Term Investments	358.88	347.15	388.03	372.65	377.13	364.48
Goodwill	291.64	292.91	291.29	330.11	280.43	241.67
Other Intangible Assets	248.23	258.75	275.16	267.1	130.8	89.48
Long-Term Deferred Tax Assets	55.07	64.19	74.68	62.79	58.92	18.24
Long-Term Deferred Charges	417.44	426.35	430.39	159.66	63.79	-
Other Long-Term Assets	80.51	85.4	58.11	108.33	123.54	48.82
Total Assets	8,581	8,816	9,384	10,144	6,562	4,497
Accounts Payable	761.17	899.26	796.14	1,788	1,111	512.65
Accrued Expenses	169.66	183.56	196.32	490.75	210.18	91.96
Short-Term Debt	48.53	66.01	20.03	303.35	389.66	144.26
Current Portion of Long-Term Debt	511.53	329.41	216.01	69.09	95.27	-
Current Portion of Leases	-	55.73	45.42	31.08	24.5	-
Current Income Taxes Payable	30.4	10.89	6.17	55.88	34.83	2.19
Current Unearned Revenue	95.38	100.98	57.5	73.63	63.68	28.79
Other Current Liabilities	69.67	59.35	53.81	204.3	189.38	204.17
Total Current Liabilities	1,686	1,705	1,391	3,016	2,119	984.02
Long-Term Debt	613.97	908.98	1,070	312.91	24	107.02
Long-Term Leases	548.83	595.99	621.38	207.33	207.34	-
Long-Term Unearned Revenue	170.55	147.98	109.99	65.25	18.26	9.53
Long-Term Deferred Tax Liabilities	68.82	46.78	91.04	70.52	7.79	3.13
Total Liabilities	3,089	3,405	3,284	3,672	2,376	1,104
Common Stock	545.46	545.46	546.04	546.03	544.4	542.75
Additional Paid-In Capital	2,041	2,041	2,067	1,958	1,799	1,635
Retained Earnings	2,822	2,742	3,293	3,628	1,728	1,262
Treasury Stock	-129.85	-129.85	-135.27	-133.1	-61.83	-44.26
Comprehensive Income & Other	55.81	-0.89	29.24	4.28	-27.3	-4.4
Total Common Equity	5,335	5,198	5,801	6,003	3,982	3,391
Minority Interest	157.94	213.2	299.17	469.17	204.53	1.81
Shareholders' Equity	5,493	5,411	6,100	6,472	4,186	3,393
Total Liabilities & Equity	8,581	8,816	9,384	10,144	6,562	4,497
Total Debt	1,723	1,956	1,973	923.77	740.77	251.28
Net Cash (Debt)	-395.13	-481.6	-6.61	1,927	476.1	1,015
Net Cash Growth	-	-	-	304.68%	-53.09%	22.64%
Net Cash Per Share	-0.74	-0.89	-0.01	3.55	0.88	1.88
Filing Date Shares Outstanding	542.18	542.18	546.04	546.03	544.4	542.75
Total Common Shares Outstanding	542.18	542.18	546.04	546.03	544.4	542.75
Working Capital	1,464	1,536	2,263	2,447	1,092	1,198
Book Value Per Share	9.84	9.59	10.62	10.99	7.31	6.25
Tangible Book Value	4,795	4,646	5,234	5,406	3,570	3,060
Tangible Book Value Per Share	8.84	8.57	9.59	9.90	6.56	5.64
Buildings	-	990.29	1,003	800.28	647.71	598.45
Machinery	-	3,545	3,120	2,335	1,820	1,335
Construction In Progress	-	437.4	693.46	1,029	341.58	188.95

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.